The president of Pfizer, Albert Bourla, said Thursday that he rejects the proposal supported by USA to temporarily suspend patents on vaccines against coronavirus covid-19, and rather suggested accelerating its production in existing plants.
In an interview with AFP, Bourla claimed that his company, which developed a vaccine together with the German BioNTech, is not “at all” in favor of the American call to lift the patents that protect the drug against covid-19.
Some more news:
- France Joins United States In Saying It Is In Favor Of Releasing Patents On COVID-19 Vaccines
- How is the battle to release patents for COVID-19 vaccines that the US has joined?
- Vladimir Putin Supports Releasing Patents for COVID-19 Vaccines
Information in development.